BDNF treatment is protective for HD cortical and striatal astrocytes, inducing an increase of GLT1 expression, but conditioned medium from HD striatal astrocytes treated with BDNF is protective for HD striatal neurons only (Saba et al., 2020). This evidence concerns the gene SLC1A2 and Huntington disease.